drugset

drugset / Trial / NCT00275925

Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures

NCT00275925 ↗

Phase 4 Completed 80 enrolled Novartis

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is aimed to evaluate the efficacy, safety and tolerability of oxcarbazepine monotherapy in adults with partial seizures.

Timeline

Start: 2005-12
Primary completion: —
Completion: 2007-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxcarbazepine	Small molecule	—	—

Indications